Back Investors

09October

bluebird bio and Novo Nordisk enter into research agreement to develop in vivo g ... Read more

01October

Novo Nordisk and Noom to partner around digital health solutions to help people ... Read more

20September

Rybelsus® (semaglutide tablets), the first GLP-1 in a tablet approved in the US ... Read more

16September

Medtronic and Novo Nordisk enter agreement to provide integrated digital solutio ... Read more

News archive

14October

Novo Nordisk A/S – Share repurchase programme ... Read more

07October

Novo Nordisk A/S – Share repurchase programme ... Read more

30September

Novo Nordisk A/S – Share repurchase programme ... Read more

23September

Novo Nordisk A/S – Share repurchase programme ... Read more

Company announcement archive

01November

Financial statement for the first nine months of 2019,

01January

Silent period ,

01October

Silent period,

17September

Handelsbanken Nordic Blue Chip Seminar , Stockholm

See calendar

Home

/Investors

Investors

Investors

Share information

Share price analysis

Next quarterly results

Next quarterly results conference call and presentation

Conference call and presentation for the first six months of 2019

Corporate reporting

Novo Nordisk Annual Report 2018

Annual Report 2018

Facts & figures

Novo Nordisk headquarters, Bagsværd, Denmark

Novo Nordisk – A focused healthcare company

Private shareholders

private-shareholder

Shareholder tools and systems for private investors

Investor materials

Investor material download centre

Investor material download centre

Contact Investor Relations

Peter Hugreffe Ankersen
Head of Investor Relations
Valdemar Borum Svarrer
Investor Relations Manager
Kristoffer Due Berg
Investor Relations Director, North America
Ann Søndermølle Rendbæk
Investor Relations Manager
Chilie Thomsen
Investor Relations Coordinator

Sign-up: Company announcements

subscribe-to-company-announcements-and-press-releases

Sign up and receive our company announcements

Financial results and events overview

Latest financial results and investor events

Get the latest financial results and investor events

SHARE Magazine

Novo Nordisk SHARE Magazine No 1 2019

Get the latest SHARE Magazine
- news for you as an investor

Capital markets day

Capital markets day 2019

Invitation to CMD 2019
- Invitation page and registration

Rybelsus^® US approval

Rybelsus US approval conference call

Access conference call
- Webcast and presentation